Bicocca Open Archive

Logo unimib boa
RE, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.191
AS - Asia 10.959
EU - Europa 9.883
SA - Sud America 1.358
Continente sconosciuto - Info sul continente non disponibili 985
AF - Africa 254
OC - Oceania 187
Totale 41.817
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.356
IT - Italia 3.395
SG - Singapore 3.145
VN - Vietnam 2.300
CN - Cina 2.293
DE - Germania 1.343
HK - Hong Kong 1.146
RU - Federazione Russa 1.097
BR - Brasile 1.000
SE - Svezia 821
CA - Canada 669
IE - Irlanda 589
GB - Regno Unito 543
IN - India 472
FR - Francia 396
UA - Ucraina 376
BD - Bangladesh 319
FI - Finlandia 265
ID - Indonesia 191
KR - Corea 186
AU - Australia 178
PL - Polonia 174
AT - Austria 150
ES - Italia 142
NL - Olanda 132
TR - Turchia 126
AR - Argentina 124
DK - Danimarca 120
JP - Giappone 113
IQ - Iraq 107
ZA - Sudafrica 101
MX - Messico 90
PK - Pakistan 77
BE - Belgio 62
IR - Iran 60
CH - Svizzera 52
TW - Taiwan 50
PH - Filippine 49
SA - Arabia Saudita 49
UZ - Uzbekistan 48
CO - Colombia 46
VE - Venezuela 44
PT - Portogallo 40
EC - Ecuador 39
CL - Cile 35
MY - Malesia 34
RO - Romania 34
BG - Bulgaria 26
KE - Kenya 26
LT - Lituania 25
CZ - Repubblica Ceca 24
EG - Egitto 24
MA - Marocco 24
GR - Grecia 23
IL - Israele 23
PY - Paraguay 23
JO - Giordania 22
NP - Nepal 20
ET - Etiopia 17
PE - Perù 17
TN - Tunisia 17
OM - Oman 16
UY - Uruguay 16
TH - Thailandia 15
AE - Emirati Arabi Uniti 14
EU - Europa 14
AZ - Azerbaigian 12
DZ - Algeria 12
JM - Giamaica 12
CR - Costa Rica 10
HN - Honduras 10
HU - Ungheria 10
KZ - Kazakistan 10
AL - Albania 9
BO - Bolivia 9
PA - Panama 9
NZ - Nuova Zelanda 8
BB - Barbados 7
CY - Cipro 7
NI - Nicaragua 7
PS - Palestinian Territory 6
BH - Bahrain 5
DO - Repubblica Dominicana 5
LB - Libano 5
LY - Libia 5
MU - Mauritius 5
AM - Armenia 4
EE - Estonia 4
GT - Guatemala 4
KG - Kirghizistan 4
LK - Sri Lanka 4
MD - Moldavia 4
NG - Nigeria 4
NO - Norvegia 4
QA - Qatar 4
RS - Serbia 4
SN - Senegal 4
SY - Repubblica araba siriana 4
BW - Botswana 3
BY - Bielorussia 3
Totale 40.781
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.788
Singapore 1.920
Ashburn 1.844
Milan 1.291
San Jose 1.215
Hong Kong 1.096
Woodbridge 867
Frankfurt am Main 738
Ho Chi Minh City 699
Fairfield 670
Chandler 632
Houston 597
Dublin 570
Wilmington 569
Hanoi 536
New York 436
Dallas 419
Los Angeles 415
Santa Clara 402
Dearborn 370
Beijing 369
Jacksonville 363
Toronto 351
Seattle 340
Chicago 252
Cambridge 246
Princeton 197
Hefei 194
Council Bluffs 188
The Dalles 182
Rome 178
Nanjing 167
Melbourne 151
Jakarta 150
Helsinki 133
Shanghai 131
Seoul 124
Vienna 123
Buffalo 122
Lauterbourg 119
Columbus 118
Orem 114
São Paulo 112
Boardman 98
Moscow 92
Guangzhou 87
Montreal 79
Denver 77
Warsaw 75
Da Nang 74
Kraków 74
Lawrence 72
Munich 72
Tokyo 72
Haiphong 68
Chennai 65
San Diego 65
London 63
Altamura 62
Dong Ket 62
Ottawa 62
Atlanta 59
Lachine 58
Phoenix 56
Nanchang 55
Brooklyn 53
Fremont 53
Brussels 52
Boston 51
Johannesburg 51
Monza 51
Turin 51
Melzo 46
Nuremberg 44
Hangzhou 43
Wayne 43
Pune 42
Baghdad 41
Changsha 41
Kunming 40
San Francisco 40
Bologna 39
Ha Long 39
Amsterdam 38
Bắc Ninh 38
Mumbai 38
Hải Dương 37
Poplar 37
Stockholm 37
Tashkent 37
Washington 37
Figino 36
New Delhi 36
Andover 34
Biên Hòa 33
Shenyang 33
Zurich 33
Dhaka 32
Genoa 32
Florence 31
Totale 25.464
Salva come PNG Salva come JPEG
Nome #
Functionalization with TAT-peptide enhances blood-brain barrier crossing in vitro of nanoliposomes carrying a curcumin-derivative to bind amyloid-β peptide 747
Trehalose-delivering nanoparticles improve the blood-brain barrier tightness 701
H-Ferritin nanoparticle-mediated delivery of antibodies across a BBB in vitro model for treatment of brain malignancies 667
New ALKBH2 and ALKBH5 inhibitors for treating glioblastoma 627
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier 619
Differential Exchange of Multifunctional Liposomes Between Glioblastoma Cells and Healthy Astrocytes via Tunneling Nanotubes 611
Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier 589
The clustering of mapoe anti-amyloidogenic peptide on nanoparticle surface does not alter its performance in controlling beta-amyloid aggregation 540
A new approach for glyco-functionalization of collagen-based biomaterials 537
An update of nanoparticle-based approaches for glioblastoma multiforme immunotherapy 536
SPRi analysis of molecular interactions of mApoE-functionalized liposomes as drug delivery systems for brain diseases 535
Mesoporous silica nanoparticles trigger mitophagy in endothelial cells and perturb neuronal network activity in a size- and time-dependent manner 524
Coupling quaternary ammonium surfactants to the surface of liposomes improves both antibacterial efficacy and host cell biocompatibility 518
The Extent of Human Apolipoprotein A-I Lipidation Strongly Affects the β-Amyloid Efflux Across the Blood-Brain Barrier in vitro 497
Investigation of Functionalized Poly(N,N-dimethylacrylamide)-block-polystyrene Nanoparticles As Novel Drug Delivery System to Overcome the Blood-Brain Barrier in Vitro 490
Biodegradable SPI-based hydrogel for controlled release of nanomedicines: a potential approach against brain tumors recurrence 483
Glibenclamide-Loaded Nanoparticles Reduce NLRP3 Inflammasome Activation and Modulate miR-223-3p/miR-7-1-5p Expression in THP-1 Cells 479
Novel Antitransferrin Receptor Antibodies Improve the Blood-Brain Barrier Crossing Efficacy of Immunoliposomes 477
Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease 465
Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide 453
Nanostructured lipid carrier formulation for delivering poorly water-soluble ITF3756 HDAC inhibitor 447
Nanomedicine for the treatment of Alzheimer's disease 441
The ability of liposomes, tailored for blood-brain barrier targeting, to reach the brain is dramatically affected by the disease state 439
Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for treatment of Alzheimer’s disease 439
Multifunctional Liposomes Modulate Purinergic Receptor-Induced Calcium Wave in Cerebral Microvascular Endothelial Cells and Astrocytes: New Insights for Alzheimer’s disease 436
Phage-displayed peptides targeting specific tissues and organs 433
Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model 423
Nanoparticle shape is the game-changer for blood-brain barrier crossing and delivery through tunneling nanotubes among glioblastoma cells 419
Enhanced brain targeting of engineered solid lipid nanoparticles 412
Oxidative stress boosts the uptake of cerium oxide nanoparticles by changing brain endothelium microvilli pattern 411
Fluorimetric detection of the earliest events in amyloid β oligomerization and its inhibition by pharmacologically active liposomes 410
Are the nanoparticles friends or foes when inhaled? 407
Multifunctional liposomes delay phenotype progression and prevent memory impairment in a presymptomatic stage mouse model of Alzheimer disease 402
The hunt for brain Aβ oligomers by peripherally circulating multi-functional nanoparticles: Potential therapeutic approach for Alzheimer disease 400
Solid Lipid Nanoparticles: a strategy to overcome the blood-brain barrier 384
The synergistic effect of chlorotoxin-mApoE in boosting drug-loaded liposomes across the BBB 367
18F-labeling syntheses and preclinical evaluation of functionalized nanoliposomes for Alzheimer's disease 358
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 358
Beta Amyloid Aggregation Inhibitors: Small Molecules as Candidate Drugs for Therapy of Alzheimer Disease 353
Prion protein structure is affected by pH-dependent interaction with membranes: a study in a model system 352
TrkA pathway activation induced by amyloid-beta (Abeta) 342
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 341
Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood-brain-barrier: Implications for therapy of Alzheimer disease 340
Nanoparticles at the neurovascular unit: in vitro and in vivo studies to assess the blood-brain barrier permeability and function 339
Reduced levels of ABCA1 transporter are responsible for the cholesterol efflux impairment in β‐amyloid‐induced reactive astrocytes: Potential rescue from biomimetic HDLs 339
Protein-functionalized nanoparticles derived from end-functional polymers and polymer prodrugs for crossing the blood-brain barrier 332
Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer’s mice 328
Tat-1-liposomes to overcome the blood-brain barrier: an in vitro study 327
Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide 324
Solid Lipid Nanoparticles: a strategy to overcome the blood-brain barrier 323
Nanoparticles at the neurovascular unit: In vitro and in vivo studies to assess the blood-brain barrier permeability and function 322
Multifunctional liposomes reduce brain β-amyloid burden and ameliorate memory impairment in alzheimer’s disease mouse models 322
The 3.0 cell communication: New insights in the usefulness of tunneling nanotubes for glioblastoma treatment 322
Modulation of intracellular Ca2+ concentration in brain microvascular endothelial cells actively induced by brain targeted liposomes 315
Targeting specific brain districts for advanced nanotherapies: A review from the perspective of precision nanomedicine 313
Amyposomes: a nanomedicine designed for treatment of Alzheimer disease 313
Abeta peptide toxicity is reduced after treatments decreasing phosphatidylethanolamine content in differentiated neuroblastoma cells 312
Liposomes functionalized to overcome the blood-brain barrier and to target amyloid-β peptide: The chemical design affects the permeability across an in vitro model 310
Effect of modified collagen on amyloid beta peptide aggregation 306
Membrane features and activity of GPI-anchored enzymes: alkaline phosphatase reconstituted in model membranes 305
Effect of nanoparticles binding ß-amyloid peptide on nitric oxide production by cultured endothelial cells and macrophages 303
Molecular dynamics simulations of doxorubicin in sphingomyelin-based lipid membranes 302
A nanomedicine-based therapeutic approach restores memory and ameliorates amyloid pathology in Alzheimer's mouse models 298
Beta-amyloid (25-35) enhances lipid metabolism and protein ubiquitination in cultured neurons 294
The fantastic voyage of solid lipid nanoparticles from the lung to the brain: non‐invasive tomographic imaging as a feasible refinement process 291
Direct and indirect air pollution effects on synaptic neurotransmission linked to the development of neurodegenerative disease 289
Study of the effects of nanoliposomes engineered for the treatment of Alzheimer's disease on the electrical activity of cortical neurons 289
Dietary nanoparticles interact with gluten peptides and alter the intestinal homeostasis increasing the risk of celiac disease 286
Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer's disease 284
Enhanced brain targeting of engineered solid lipid nanoparticles 280
Enhanced folate binding of cultured fibroblasts from Alzheimer's disease patients 277
Preparation and characterization of lipid-based nanoparticles binding with high affinity amyloid-beta(1-42) peptide 274
In Vitro Biocompatibility and Endothelial Permeability of Branched Polyglycidols Generated by Ring-Opening Polymerization of Glycidol with B(C6F5)3 under Dry and Wet Conditions 270
Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide 268
Potential nanotherapeutic approach for Alzheimer's disease: in vitro clearance of beta-amyloid across the blood-brain barrier by multifunctional liposomes 267
Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic mice 262
Amyposomes, a nanotechnological chaperone with anti-amyloidogenic activity 257
Development of a 3D in vitro model mimicking the changes occurring at the blood-brain barrier during Alzheimer’s disease 256
Lipid-based nanoparticles with high binding affinity for amyloid-b1e42 peptide 254
Liposomes functionalized with acidic lipids rescue Aβ-induced toxicity in murine neuroblastoma cells 248
Nanotechnology for neurodegenerative disorders 248
A novel, glutathione-activated prodrug of pimasertib loaded in liposomes for targeted cancer therapy 247
The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue 247
Synthesis of functionalized [F-18]liposomes for preclinical PET imaging in Alzheimer's disease 246
Lipid-based nanoparticles (NPs) with high binding affinity for amyloid-beta1-42 peptide modulate the barrier properties of a monolayer of endothelial cells 246
PEGylated solid lipid nanoparticles for brain delivery of lipophilic kiteplatin Pt(IV) prodrugs: An in vitro study 246
Radiation and adjuvant drug-loaded liposomes target glioblastoma stem cells and trigger in-situ immune response 245
The interaction of complement system with abeta-binding liposomes: towards engineering of safer vesicles for the management of alzheimer's disease 244
Nanoparticle-based strategy to cross the BBB: the potential for the therapy of Alzheimer’s disease 244
Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation 239
Multi-functional liposomes prevent memory impairment and slow down brain B-amyloid deposition in a mouse model of Alzheimer’s disease. 239
Dual Functionalized Liposomes for Selective Delivery of Poorly Soluble Drugs to Inflamed Brain Regions 239
Antibody-functionalized polymer nanoparticle leading to memory recovery in Alzheimer's disease-like transgenic mouse model 238
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 235
Attempt of neuroprotective response of rat cultured hippocampal neurons against Abeta insult 234
Development of a New Vaccine Adjuvant System Based on the Combination of the Synthetic TLR4 Agonist FP20 and a Synthetic QS-21 Variant 230
Applicability of [11C]PIB micro-PET imaging for in vivo follow-up of anti-amyloid treatment effects in APP23 mouse model 228
From the lungs to the brain: the fantastic voyage of nanoparticles targeting beta-amyloid 228
Nanoparticles at the neurovascular unit: in vitro and in vivo studies to assess the blood-brain barrier permeability and function 228
Nanotechnology for neurodegenerative disorders 217
Totale 35.978
Salva come PNG Salva come JPEG
Categoria #
all - tutte 120.424
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 120.424
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.987 0 204 198 209 148 188 164 136 114 164 181 281
2022/20232.938 359 818 293 295 198 432 57 140 166 33 86 61
2023/20242.332 64 81 132 161 240 542 410 117 134 55 114 282
2024/20255.643 280 461 393 305 456 370 387 224 618 855 530 764
2025/202616.876 2.445 987 1.230 1.650 1.851 744 2.207 881 1.289 1.457 929 1.206
2026/20271.302 1.043 259 0 0 0 0 0 0 0 0 0 0
Totale 41.817